☆ 4.6 Letter

Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Journal

AMERICAN JOURNAL OF HEMATOLOGY

Volume 98, Issue 9, Pages E233-E236

Publisher

WILEY

DOI: 10.1002/ajh.27005

Keywords

-

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.